137 related articles for article (PubMed ID: 10925963)
1. Bone marrow micrometastases and gastrointestinal cancer detection and significance.
Maguire D; O'Sullivan GC; Collins JK; Morgan J; Shanahan F
Am J Gastroenterol; 2000 Jul; 95(7):1644-51. PubMed ID: 10925963
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
Putz E; Witter K; Offner S; Stosiek P; Zippelius A; Johnson J; Zahn R; Riethmüller G; Pantel K
Cancer Res; 1999 Jan; 59(1):241-8. PubMed ID: 9892213
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy.
Ryan P; McCarthy S; Kelly J; Collins JK; Dunne C; Grogan L; Breathnach O; Shanahan F; Carey PD; Walsh TN; O'Sullivan GC
J Surg Res; 2004 Mar; 117(1):121-6. PubMed ID: 15013722
[TBL] [Abstract][Full Text] [Related]
5. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer: flow cytometric methods for detection of bone marrow micrometastases.
Hussain M; Kukuruga M; Biggar S; Sakr W; Cummings G; Ensley J
Cytometry; 1996 Mar; 26(1):40-6. PubMed ID: 8809479
[TBL] [Abstract][Full Text] [Related]
7. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
[TBL] [Abstract][Full Text] [Related]
8. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.
Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N
Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of disseminated tumor cells in breast cancer.
Slade MJ; Coombes RC
Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
[TBL] [Abstract][Full Text] [Related]
11. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases.
Sheehan KM; Cahill RA; McGreal G; Steele C; Byrne MF; Kirwan WO; Kay EW; Fitzgerald DJ; Redmond HP; Murray FE
Dig Liver Dis; 2004 Jun; 36(6):392-7. PubMed ID: 15248379
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow micrometastasis in breast cancer.
Ozbas S; Dafydd H; Purushotham AD
Br J Surg; 2003 Mar; 90(3):290-301. PubMed ID: 12594663
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
16. Biological behaviour and clinical implications of micrometastases.
Kell MR; Winter DC; O'Sullivan GC; Shanahan F; Redmond HP
Br J Surg; 2000 Dec; 87(12):1629-39. PubMed ID: 11122176
[TBL] [Abstract][Full Text] [Related]
17. Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer.
Bjørnland K; Flatmark K; Mala T; Mathisen O; Bakka A; Aasen AO; Bergan A; Søreide O; Fodstad O
J Surg Oncol; 2003 Apr; 82(4):224-7. PubMed ID: 12672004
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of bone marrow micrometastases of breast tumors].
Dubecz S; Csuka O; Török K; Vasas N; Péley G; Doleschal Z; Sulyok Z; Láng I; Köves I
Magy Seb; 2003 Aug; 56(3-4):108-12. PubMed ID: 14619093
[TBL] [Abstract][Full Text] [Related]
19. [Micrometastases in pediatric oncology].
Bernard F; Aerts I; Margueritte G; Astruc J
Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
[TBL] [Abstract][Full Text] [Related]
20. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M
BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
